The Journal seeks to become the most reliable, first-choice Pan-Nigerian information and public knowledge platform. The Journal Nigeria is a serious Journalism from an African Worldview
The National Agency for the Control of AIDS has confirmed that Lenacapavir, Nigeria’s newly introduced long-acting HIV prevention injection, will not be administered to pregnant women due to the absence of sufficient clinical evidence on its effects during pregnancy. Temitope Ilori, Director-General of NACA, disclosed this restriction during a media parley organised by the…
Nigerians have begun a frantic search for Lenacapavir, a newly introduced injectable for HIV prevention, ahead of its official nationwide rollout. Individuals, particularly those in “discordant” relationships where one partner is HIV-positive, are reportedly besieging health facilities and NGOs to secure the drug. The Federal Government has already received its first tranche of 11,520 doses,…
Nigeria will receive its first consignments of Lenacapavir, a ground-breaking HIV prevention drug, this month. The National Agency for the Control of AIDS (NACA) confirmed on Monday that the country is ready to deploy the twice-yearly injectable. This shift from daily oral pills to a biannual shot marks a significant pivot in the national strategy…
